4//SEC Filing
Lyons Ruth Anne 4
Accession 0001209191-12-045075
CIK 0001013606other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:06 PM ET
Size
5.3 KB
Accession
0001209191-12-045075
Insider Transaction Report
Form 4
Lyons Ruth Anne
VP Global Marketing
Transactions
- Award
Common Stock
2012-09-09$12.62/sh+28,944$365,273→ 28,944 total
Footnotes (4)
- [F1]25% vesting to occur upon the achievement of Nellix device revenue target for a month.
- [F2]25% vesting to occur upon U.S. regulatory approval of Nellix device.
- [F3]25% vesting to occur upon U.S. regulatory approval of Ventana device.
- [F4]25% vesting to occur upon U.S.regulatory approval of a second-generation AFX device.
Documents
Issuer
ENDOLOGIX INC /DE/
CIK 0001013606
Entity typeother
Related Parties
1- filerCIK 0001529074
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:06 PM ET
- Size
- 5.3 KB